Regulators assess PB016 vedolizumab biosimilar applications
Researchers highlight minimally invasive monitoring potential
Updated Date: Thu, 23 Jul 2026 00:00:00 EDT
Updated Date: Thu, 23 Jul 2026 00:00:00 EDT
Updated Date: Thu, 23 Jul 2026 00:00:00 EDT
Updated Date: Thu, 23 Jul 2026 00:00:00 EDT
Updated Date: Thu, 23 Jul 2026 00:00:00 EDT
First-in-human evaluation of infinitopes’ therapeutic platform
First IBAT inhibitor for PBC cholestatic pruritus
Updated Date: Wed, 22 Jul 2026 00:00:00 EDT